COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.
Reuven Schore, MD
-
Fellowship Program, Pediatric Hematology/Oncology, 2006
Cincinnati Children's Hospital Medical Center
-
Residency Program, Pediatrics, 2003
North Shore University Hospital at Manhasset
-
Internship Program, Pediatrics, 2001
North Shore University Hospital at Manhasset
-
MD, 2000
SUNY Health Science Center at Brooklyn
-
BA, 1995
Brooklyn College of the City University of New York
-
- American Board of Pediatrics/Hematology-Oncology
- American Board of Pediatrics
National Provider ID: 1033204227
Reuven Schore, M.D., is a pediatric oncologist and a member of the Leukemia/Lymphoma Program at Children's National Hospital.
Dr. Schore is the vice chair for a Children's Oncology Group study investigating intravenous treatments for patients with high-risk acute lymphoblastic leukemia (ALL).
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
Outside Interests
- Sigma Tau Pharmaceuticals
- Merck, Sharpe & Dohme Corporation
- Millenium Pharmaceuticals